<DOC>
	<DOC>NCT00158834</DOC>
	<brief_summary>This study was designed to evaluate if, in children with asthma, a stepwise treatment (five levels varying from once daily fluticasone propionate 100mcg until twice daily a fixed combination of salmeterol and fluticasone propionate 50/500 mcg) based on symptom scores alone results in a sub-optimal treatment when compared to treatment based on cumulative symptom scores and bronchial hyperresponsiveness (PD20 methacholine).</brief_summary>
	<brief_title>Pediatric Asthma Study Using Stepwise Treatment With Two Food And Drug Administration Approved Asthma Medications</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Fluticasone</mesh_term>
	<mesh_term>Salmeterol Xinafoate</mesh_term>
	<criteria>Inclusion criteria: Children with a documented history of asthma. Using inhaled steroids from 100 mcg up to 500 mcg twice daily for at least 1 month before study start. Must be able to perform reproducible lung function tests. Must have a positive RAST or skin prick test. During the treatment period, the patient has to be hyperreactive (defined as PD20 methacholine &lt; 150 mcg) and/or have a cumulative symptom score of 14 based on the daily record card filled in during the last 2 weeks of the runin period. Exclusion criteria: History of an acute upper or lower respiratory tract infection, middle ear, or sinus infection 4 weeks prior to visit 1. Admitted to hospital due to a respiratory disease 4 weeks prior to visit 1. Received oral corticosteroids within 4 weeks prior to visit 1. Existence of any disorder that affects growth. Clinical or laboratory evidence of a serious systemic disease, or suspected hypersensitivity to corticosteroids, lactose or short/long acting B2agonists.</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>16 Years</maximum_age>
	<verification_date>October 2008</verification_date>
	<keyword>Children</keyword>
	<keyword>Asthma</keyword>
	<keyword>bronchial hyperresponsiveness</keyword>
	<keyword>symptoms</keyword>
</DOC>